Evidence map›Paper›PMID 37888075›Full record

ArticleJournal of personalized medicine2023

Safety and Efficacy of Prestige Coils for Embolization of Vascular Abnormalities: The Embo-Prestige Study.

Julien Frandon, Romaric Loffroy, Clement Marcelin, Hélène Vernhet-Kovacsik, Joel Greffier, Djamel Dabli, Skander Sammoud, Pierre Marek, Olivier Chevallier, Jean-Paul Beregi and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of personalized medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. OnyxGels (Basel, Switzerland) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Julien FrandonDepartment of Medical Imaging, IPI Plateform, Nîmes University Hospital, University of Montpellier, Medical Imaging Group Nîmes, IMAGINE, 30029 Nîmes, France.ORCID 0000-0001-7816-8178
Romaric LoffroyDepartment of Radiology, CHU Dijon-Bourgogne, 21079 Dijon, France.ORCID 0000-0002-3107-5967
Clement MarcelinCentre Hospitalier Universitaire de Bordeaux, Service d'Imagerie Diagnostique et Thérapeutique de l'Adulte, Hopital Pellegrin, 33076 Bordeaux, France.ORCID 0000-0002-2328-0952
Hélène Vernhet-KovacsikDepartment of Radiology, CHU of Montpellier, Arnaud de Villeneuve Hospital, 34090 Montpellier, France.
Joel GreffierDepartment of Medical Imaging, IPI Plateform, Nîmes University Hospital, University of Montpellier, Medical Imaging Group Nîmes, IMAGINE, 30029 Nîmes, France.ORCID 0000-0002-1735-5129
Djamel DabliDepartment of Medical Imaging, IPI Plateform, Nîmes University Hospital, University of Montpellier, Medical Imaging Group Nîmes, IMAGINE, 30029 Nîmes, France.ORCID 0000-0003-1003-1196
Skander SammoudDepartment of Medical Imaging, IPI Plateform, Nîmes University Hospital, University of Montpellier, Medical Imaging Group Nîmes, IMAGINE, 30029 Nîmes, France.
Pierre MarekInterventional Radiology Department, Rangueil Hospital, University Hospital of Toulouse, 31400 Toulouse, France.
Olivier ChevallierDepartment of Radiology, CHU Dijon-Bourgogne, 21079 Dijon, France.ORCID 0000-0002-3888-3174
Jean-Paul BeregiDepartment of Medical Imaging, IPI Plateform, Nîmes University Hospital, University of Montpellier, Medical Imaging Group Nîmes, IMAGINE, 30029 Nîmes, France.
Hervé RousseauInterventional Radiology Department, Rangueil Hospital, University Hospital of Toulouse, 31400 Toulouse, France.
Université de Montpellier · FRCHU Dijon Bourgogne · FRHôpital Rangueil · FRHôpital Arnaud de Villeneuve · FRInserm · FR

Funding

This research was funded by Balt Extrusion SAS. NA
6 · The paper itself

Abstract

A wide variety of coils are available for vascular embolization. This study aimed to evaluate the safety and efficacy of a new Prestige coil. We carried out retrospective analysis of a multicenter's registry data collected between February 2022 and November 2022. The choice of embolization agent used to treat peripheral vascular anomalies was left to the investigator's discretion. Patients for whom at least one Prestige coil was used were included in Series 1. All other patients were included in Series 2. Efficacy and safety were evaluated. Patients were followed up for one month. In total, 220 patients were included, 110 in each series. Patients included 149 men (67.7%) and 71 women (32.3%), with a median age of 62.5 years (IQR: 35.8-73). Patient ages were similar in the two series. Complete occlusion of the targeted vessel was reported in 96.4% (

Indexed as

coilsembolizationinterventional radiologyperipheral vascular lesionssafety

Identifiers

PMID37888075
PMCPMC10608704
OpenAlexW4387389249

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.